LinkedIn Profile

Access Synthelis historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:synthelis 663241 Jun 3rd, 2019 12:00AM SYNTHELIS 703 9.00 Open Biotechnology Jun 3rd, 2019 05:14PM Jun 3rd, 2019 05:14PM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Open protein identification, protein characterization, protein production, protein delivery, cell-free, antibody development, vaccine development, screening, display technology, in vitro diagnostics, structural biology, protein in detergent, protein in proteoliposome Open BIOPOLIS, 5 Avenue du Grand Sablon La Tronche FR 38700 Health Care Pharmaceuticals & Biotechnology
private:synthelis 663241 Feb 17th, 2018 12:00AM SYNTHELIS 494 8.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Health Care Pharmaceuticals & Biotechnology
private:synthelis 663241 Feb 16th, 2018 12:00AM SYNTHELIS 494 8.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Health Care Pharmaceuticals & Biotechnology
private:synthelis 663241 Feb 15th, 2018 12:00AM SYNTHELIS 494 8.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Health Care Pharmaceuticals & Biotechnology
private:synthelis 663241 Feb 14th, 2018 12:00AM SYNTHELIS 494 8.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Health Care Pharmaceuticals & Biotechnology
private:synthelis 663241 Feb 13th, 2018 12:00AM SYNTHELIS 494 8.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Health Care Pharmaceuticals & Biotechnology
private:synthelis 663241 Feb 12th, 2018 12:00AM SYNTHELIS 494 8.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Health Care Pharmaceuticals & Biotechnology
private:synthelis 663241 Feb 11th, 2018 12:00AM SYNTHELIS 494 8.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Health Care Pharmaceuticals & Biotechnology
private:synthelis 663241 Feb 10th, 2018 12:00AM SYNTHELIS 494 8.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Health Care Pharmaceuticals & Biotechnology
private:synthelis 663241 Feb 9th, 2018 12:00AM SYNTHELIS 494 8.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Synthelis provides a solution to a well known challenge in terms of biotechnological production – namely the synthesized production of membrane proteins. Around 30% of the human genome is coded for protein membranes. This family of proteins is involved in key biological processes such as cellular signaling, energy transduction or metabolic transportation. Anomalies affecting their structure or function can be directly or indirectly linked to a large number of pathologies. Consequently these molecules are the target for a large number of medicines currently planned for development. The significant difficulties associated with their production, purification and crystallization in comparison with soluble proteins demonstrates the necessity for developing new manufacturing processes. Using a cutting-edge process, Synthelis produces functional membrane proteins in soluble or proteoliposome form. These membrane proteins can be used in structural studies or functional/electrophysiological studies, the development of vaccines or even high throughput molecule/ligand screening. Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.